Natera touts data supporting personalized ctDNA testing
July 7, 2020 -- Natera is highlighting clinical data that supports the efficacy of personalized circulating tumor DNA (ctDNA) testing for oligometastatic colorectal cancer.
Companion diagnostics survive COVID-19 with small nick
July 6, 2020 -- The COVID-19 crisis has had a slightly negative, but not critical, impact on the market for companion diagnostics, according to a new market report from market research firm Kalorama Information.  Discuss
AI predicts which patients to test for pancreatic cancer
July 6, 2020 -- Researchers created a model utilizing artificial intelligence (AI) that identified patients at an increased risk for pancreatic cancer who could benefit from early screening with a blood test. They presented their findings from a pilot study using the model on July 2 at the virtual European Society for Medical Oncology World Congress on Gastrointestinal Cancer.  Discuss
Myriad partners with OptraHealth on cancer chatbot
July 6, 2020 -- Myriad Genetics is partnering with OptraHealth to develop a chatbot named Gene that will offer patients information on hereditary cancer.
Is whole genome sequencing for children with rare diseases worth the price?
June 30, 2020 -- Proposed legislation that would expand Medicaid coverage to include the use of whole genome sequencing for diagnosing some rare pediatric diseases has pros and cons, according to an opinion article published by Harvard Medical School researchers online June 29 in JAMA Pediatrics.  Discuss
Nucleix highlights data for urine test in detecting bladder cancer
June 30, 2020 -- Liquid biopsy firm Nucleix said that its methylation-based Bladder EpiCheck urine test produced strong results for detecting high-risk, non-muscle invasive bladder cancer in a study published online June 11 in the Journal of Clinical Pathology.
AI helps classify colon cancer tissue samples
June 29, 2020 -- Working with infrared microscopes based on quantum cascade lasers and artificial intelligence (AI) can enable accurate classification of colon cancer tissue samples in a marker-free and automated way, according to a research team from the Prodi Centre for Protein Diagnostics at Ruhr-Universität Bochum in Germany.
Machine learning could 'transform' cervical cancer screening, NCI researchers report
June 25, 2020 -- An artificial intelligence system applied to dual-stain cervical cancer testing was accurate and could reduce unnecessary follow-up colposcopies, with potentially transformative effects for patients, according to a study published June 25 by National Cancer Institute (NCI) researchers.  Discuss
AI-driven DNA methylation liquid biopsy shows promise in brain and kidney cancer
June 24, 2020 -- A new liquid biopsy method based on DNA methylation and powered by artificial intelligence (AI) demonstrated promising performance at classifying brain cancers and identifying whether kidney tumors were present in a pair of studies published online on June 22 in Nature Medicine.  Discuss
FDA debuts website for patient-reported cancer outcomes
June 24, 2020 -- The U.S. Food and Drug Administration (FDA) has unveiled Project Patient Voice, a new pilot program for communicating patient-reported outcomes from cancer clinical trials.